[Lincomycin in the treatment of anaerobic infections in obstetric and gynecologic surgery].

PubWeight™: 0.75‹?›

🔗 View Article (PMID 7133537)

Published in Minerva Ginecol on June 01, 1982

Authors

B Dainelli, A Magni, F Maragoni, P Stentella, F Filadoro

Articles by these authors

Randomized trial of fenretinide to prevent second breast malignancy in women with early breast cancer. J Natl Cancer Inst (1999) 4.04

Coccoid Helicobacter pylori not culturable in vitro reverts in mice. Microbiol Immunol (1994) 1.79

Distribution of axillary node metastases by level of invasion. An analysis of 539 cases. Cancer (1987) 1.48

Helicobacter pylori: a fickle germ. Microbiol Immunol (1994) 1.47

Enterococcus flavescens sp. nov., a new species of enterococci of clinical origin. Int J Syst Bacteriol (1992) 1.36

Five-year administration of fenretinide: pharmacokinetics and effects on plasma retinol concentrations. J Clin Oncol (1993) 1.25

Commercial identification systems often fail to identify Providencia stuartii. J Clin Microbiol (1988) 1.14

Plasma retinol level reduction by the synthetic retinoid fenretinide: a one year follow-up study of breast cancer patients. Cancer Res (1989) 1.12

New plate medium for screening and presumptive identification of gram-negative urinary tract pathogens. J Clin Microbiol (1988) 1.06

Helicobacter pylori isolated from stomach corpus and antrum: comparison of DNA patterns. J Infect (1996) 1.06

Piliated Bacteroides fragilis strains adhere to epithelial cells and are more sensitive to phagocytosis by human neutrophils than nonpiliated strains. Infect Immun (1984) 0.95

The effect of oxygen on the growth and cell morphology of Helicobacter pylori. FEMS Microbiol Lett (1998) 0.93

Hydrocephalus, bronchiectasis, and ciliary aplasia. Arch Dis Child (1990) 0.92

Chest x-ray survey in breast cancer follow-up--a contrary view. Tumori (1987) 0.91

Recovery of Helicobacter pylori ATCC43504 from a viable but not culturable state: regrowth or resuscitation? APMIS (1998) 0.91

Alpha interferon therapy in patients with hepatitis infection undergoing organ transplantation. Transplant Proc (1989) 0.91

In vitro activity of ciprofloxacin against aerobic bacteria isolated in a southern European hospital. Antimicrob Agents Chemother (1987) 0.89

Identification of respiratory isolates of Stenotrophomonas maltophilia by commercial biochemical systems and species-specific PCR. J Microbiol Methods (2005) 0.89

Tolerability of the synthetic retinoid Fenretinide (HPR). Eur J Cancer Clin Oncol (1989) 0.88

A retrospective study of audiological function in a group of congenital hypothyroid patients. Int J Pediatr Otorhinolaryngol (1980) 0.87

o-Nitrophenyl-beta-D-galactopyranoside-urease-indole broth, a new composite tube medium for Salmonella screening. J Clin Microbiol (1986) 0.86

Enhanced clearing of Helicobacter pylori after omeprazole plus roxithromycin treatment. FEMS Microbiol Lett (1991) 0.85

Magnetization switching and microwave oscillations in nanomagnets driven by spin-polarized currents. Phys Rev Lett (2005) 0.85

Incidence of hemagglutination activity among pathogenic and non-pathogenic Bacteroides fragilis strains and role of capsule and pili in HA and adherence. FEMS Microbiol Lett (1989) 0.84

New plate medium for growth and detection of urease activity of Helicobacter pylori. J Clin Microbiol (1992) 0.84

[A new method of fixation of Trichomonas vaginalis for electron microscopy with preservation of cellular monolayers]. Riv Biol (1969) 0.84

Culture filtrates and whole heat-killed Candida albicans stimulate human monocytes to release interleukin-6. New Microbiol (1993) 0.83

Twelve aberrant strains of Staphylococcus aureus subsp. aureus from clinical specimens. J Clin Microbiol (1993) 0.83

Preincubation of Candida albicans strains with amphotericin B reduces tumor necrosis factor alpha and interleukin-6 release by human monocytes. Antimicrob Agents Chemother (1993) 0.82

Retinoids, breast cancer and NK cells. Br J Cancer (1993) 0.82

Regression rate of clinical HPV infection of the lower genital tract during pregnancy after laser CO2 surgery. Clin Exp Obstet Gynecol (2006) 0.82

Cervical intraepithelial neoplasia and bacterial vaginosis: correlation or risk factor? Eur J Gynaecol Oncol (1997) 0.82

Multiple primary neoplasms. Considerations on 42 cases. Eur J Gynaecol Oncol (1995) 0.82

Chemoprevention trial of contralateral breast cancer with fenretinide. Rationale, design, methodology, organization, data management, statistics and accrual. Tumori (1998) 0.81

The risk of breast cancer subsequent to histologic diagnosis of benign intraductal papilloma follow-up study of 339 cases. Tumori (1991) 0.81

Persistent vulvovaginal candidiasis: systemic treatment with oral fluconazole. Clin Exp Obstet Gynecol (1994) 0.81

Chest X-ray survey in the follow-up of breast cancer patients. Br J Cancer (1989) 0.80

Effect of cyclosporin A on B cell maturation and differentiation. Drugs Exp Clin Res (1991) 0.80

T-mod pathway, a reduced sequence for identification of gram-negative urinary tract pathogens. J Clin Microbiol (1989) 0.80

Reactivity and protective capacity of a polyclonal antiserum derived from mice immunized with antibiotic exposed Escherichia coli. J Antimicrob Chemother (1993) 0.80

Modification of Pseudomonas aeruginosa virulence factors by sub-inhibitory concentrations of antibiotics. J Chemother (1992) 0.80

Fine structure of chromatic granules in Trichomonas vaginalis Donné. Experientia (1970) 0.80

Emergency reoperation for primary tissue failure of porcine bioprostheses. Am J Cardiol (1987) 0.80

Study of IgG antibodies to Pseudomonas aeruginosa in early cystic fibrosis infection. New Microbiol (1998) 0.79

The release of TNF-alpha and IL-6 from human monocytes stimulated by filtrates of Candida albicans after treatment with amphotericin B. J Antimicrob Chemother (1994) 0.79

Microbiological evidence of Helicobacter pylori from dental plaque in dyspeptic patients. New Microbiol (1995) 0.78

Aortic valve replacement with the Hancock standard, Björk-Shiley, and Lillehei-Kaster prostheses. A comparison based on follow-up from 1 to 15 years. J Thorac Cardiovasc Surg (1989) 0.78

Antibiotics at sub-inhibitory concentrations and virulence factors of Pseudomonas aeruginosa. New Microbiol (1998) 0.78

Improvement of uterine artery Doppler velocimetry indices after metroplasty in arcuate uteri. Eur J Obstet Gynecol Reprod Biol (2006) 0.77

Differential effect of human and murine polyclonal and monoclonal antisera on TNF-alpha production by human monocytes. J Chemother (1993) 0.77

Diagnostic value of cytokine assays in cerebrospinal fluid in culture-negative, polymerase chain reaction-positive bacterial meningitis. Eur J Clin Microbiol Infect Dis (2000) 0.77

Incidence of lower respiratory tract infections caused by Mycoplasma, Chlamydia and Legionella: an Italian Multicenter Survey. J Chemother (1994) 0.77

Evidence for an oral-faecal transmission of Helicobacter pylori infection in an experimental murine model. APMIS (1999) 0.76

Purification and characterisation of two GST's forms from Rhizobium leguminosarum with a high affinity to herbicides. Int J Immunopathol Pharmacol (2003) 0.76

Functional integration approach to hysteresis. Phys Rev E Stat Phys Plasmas Fluids Relat Interdiscip Topics (1999) 0.76

Failure to detect Helicobacter pylori in nasal mucus in H pylori positive dyspeptic patients. J Clin Pathol (1995) 0.75

Correlation study of two routine bacteriology systems with previously characterised strains. New Microbiol (2002) 0.75

FIGO Stage I endometrial carcinoma: evaluation of lung metastases and follow-up. Eur J Gynaecol Oncol (2008) 0.75

Double sugar-tyrosine medium improves O-1 phage Salmonella screening. J Clin Microbiol (1992) 0.75

Adherence of Pseudomonas aeruginosa elastase deficient mutant. Microbiologica (1990) 0.75

Teicoplanin, antibiotics from Actinoplanes teichomyceticus nov. sp. VIII. Opening of the polypeptide chain of teicoplanin aglycone under hydrolytic conditions. J Antibiot (Tokyo) (1987) 0.75

Study of cefoperazone's in vitro antibacterial activity, in comparison with other cephalosporins, on 512 gram-negative bacterial strains. G Batteriol Virol Immunol (1982) 0.75

Substrate interaction with 5alpha-reductase enzyme: influence of the 17beta-chain chirality in the mechanism of action of 4-azasteroid inhibitors. Steroids (2001) 0.75

Role of alkaline protease and elastase in the adherence of Pseudomonas aeruginosa to WEHI cells. Microbiologica (1989) 0.75

The viral lesion (HPV) of the lower genital tract in teen agers: clinical and therapeutic aspects. Eur J Gynaecol Oncol (1989) 0.75

[Colpo-cyto-histological correlations in intraepithelial lesions of the uterine cervix]. Minerva Ginecol (1992) 0.75

[Typology and etiopathogenesis of breast pain]. Minerva Med (1985) 0.75

The Hancock II porcine bioprosthesis. A preliminary report. J Thorac Cardiovasc Surg (1989) 0.75

Results of simultaneous replacement of one left-sided cardiac valve with a mechanical prosthesis and the other left-sided valve with a bioprosthesis. Am J Cardiol (1988) 0.75

[Hysteroscopy in septate uterus. Diagnostic and therapeutic features]. Minerva Ginecol (1995) 0.75

A practical route for the synthesis of 17 substituted steroidal 3-thioxamides. Steroids (1997) 0.75

[Diagnosis and therapy of low-risk endometrial hyperplasia. Experience with LH-RH-A]. Minerva Ginecol (1992) 0.75

[Study of fecal antigens against Helicobacter pylori as non-invasive test compared with the 13C-urea breath-test. Personal experience]. G Chir (2003) 0.75

Outer membrane proteins and lipopolysaccharide changes after exposure of Pseudomonas aeruginosa to antibacterial drugs. New Microbiol (1993) 0.75

[Intraepithelial cervical lesions: colpo-microcolposcopic diagnosis]. Minerva Ginecol (1993) 0.75

Subinhibitory concentrations of antibacterial drugs and Pseudomonas aeruginosa virulence factors. New Microbiol (1993) 0.75

[Psychological aspects of pregnant women with breast cancer and the desire of mastectomy patients to become pregnant]. Minerva Psichiatr (1985) 0.75

Pneumonia complicating abdominal sepsis: an experimental model of hematogenous contamination of the lung. J Chemother (1992) 0.75

Outer membrane alterations in Pseudomonas aeruginosa after five-day exposure to quinolones and carbapenems. Drugs Exp Clin Res (1995) 0.75

[Anaerobes: bacteriologic diagnosis]. Nuovi Ann Ig Microbiol (1983) 0.75

Determinations of tissue levels of cefatrizine in blood, lungs and bronchi. Drugs Exp Clin Res (1985) 0.75

[The staging of breast carcinoma]. Minerva Ginecol (1984) 0.75

Vulvar and penile HPV lesions: laser surgery and topic anaesthesia. Clin Exp Obstet Gynecol (1993) 0.75

[Blue nevus of the endocervix]. Minerva Ginecol (1996) 0.75

Pain evaluation during carbon dioxide laser vaporization for cervical intraepithelial neoplasia: a randomized trial. Clin Exp Obstet Gynecol (1994) 0.75

[Laser CO2: results of treatment of HPV lesions in male the partner]. Minerva Ginecol (1992) 0.75

Psychologic aspects of patients participating in a phase I study with the synthetic retinoid 4-hydroxyphenyl retinamide. Tumori (1988) 0.75

Mitral valve replacement with the Hancock, Björk-Shiley and Lillehei-Kaster prostheses. A comparison based on a 15-year follow-up. Eur J Cardiothorac Surg (1989) 0.75

Management of human papilloma virus vulvo-perineal infection with systemic beta-interferon and thymostimulin in HIV-positive patients. Int J Gynaecol Obstet (1994) 0.75

Hancock bioprosthetic valve failure: causes, and results of reoperation. Tex Heart Inst J (1988) 0.75

AP-PCR typing of Pseudomonas aeruginosa isolated from patients with cystic fibrosis. New Microbiol (2001) 0.75

[Viral and/or intraepithelial lesions of the lower female genital tract: diagnostic and prognostic value of in situ molecular hybridization]. Minerva Ginecol (1992) 0.75

Aztreonam biliary excretion in bile duct ligated jaundiced rats. J Chemother (1991) 0.75

Influence of aztreonam-netilmicin association on outer membrane proteins of P. aeruginosa strains. Microbiologica (1991) 0.75

[Sensitivity in vitro of 192 Proteus strains to several aminoglycosides]. Ann Sclavo (1981) 0.75

[HR 756. In vitro microbiological activity against various species of anaerobic bacteria]. G Ital Chemioter (1981) 0.75

["In vitro" microbiological activity of tinidazole compared to 64 anaerobic bacterial strains recently isolated (author's transl)]. Ann Sclavo (1982) 0.75